Brown & Brown, Inc. announces entry into accelerated share repurchase program
Rhea-AI Summary
Brown & Brown (NYSE: BRO) entered an accelerated share repurchase (ASR) with Bank of America for $250 million of common stock on Feb. 12, 2026. The ASR is part of a previously approved $1.5 billion board buyback authorization announced Oct. 22, 2025.
Positive
- $250 million ASR executed with Bank of America on Feb. 12, 2026
- Repurchase is part of a $1.5 billion board-approved authorization from Oct. 22, 2025
Negative
- None.
News Market Reaction – BRO
On the day this news was published, BRO gained 3.75%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BRO was down 0.87% while key peers WTW (-2.59%), AJG (-3.03%), AON (-1.70%) and MMC (-1.36%) also traded lower, with ERIE the only notable gainer at +1.37%. The buyback news appears more company-specific than a broad sector catalyst.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 26 | Q4/FY2025 earnings | Positive | +0.6% | Strong 2025 revenue and adjusted EPS update with mixed organic trends. |
| Jan 26 | Leadership change | Negative | +0.6% | Announcement of Chief Legal Officer’s passing and interim appointment. |
| Jan 22 | Business expansion | Positive | +0.7% | Launch of fully integrated National Healthcare Practice with 140+ professionals. |
| Jan 21 | Dividend declaration | Positive | +0.7% | Board declared regular quarterly cash dividend of $0.165 per share. |
| Dec 31 | Earnings schedule | Neutral | -0.7% | Announcement of dates for Q4 2025 earnings release and conference call. |
Recent news including earnings, a new healthcare practice and dividend declarations generally saw modestly positive 24-hour price reactions.
Over the last few weeks, Brown & Brown reported Q4 and FY2025 results on Jan 26, 2026, showing total revenues of $1.6B in the quarter and $5.9B for 2025, with adjusted diluted EPS of $0.93 in Q4. Around the same time, the company announced the passing of its Chief Legal Officer and launched a fully integrated National Healthcare Practice on Jan 22, 2026. A quarterly dividend of $0.165 per share was also declared. These developments collectively coincided with small positive price reactions.
Market Pulse Summary
This announcement outlines a $250 million accelerated share repurchase as part of a broader $1.5 billion authorization, adding to Brown & Brown’s recent stream of capital-return and strategic updates. Context includes 2025 commissions and fees of $5,763 million and total debt of $7,613 million. Investors may track how the buyback interacts with leverage levels, future earnings reports, and any further updates on business integration and segment performance.
Key Terms
AI-generated analysis. Not financial advice.
DAYTONA BEACH, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Brown & Brown, Inc. (NYSE: BRO) (the “Company”) today announced that it has entered into an accelerated share repurchase program (ASR) with Bank of America, N.A. for
About Brown & Brown, Inc.
Brown & Brown, Inc. (NYSE: BRO) is a leading insurance brokerage firm delivering comprehensive and customized insurance solutions and specialization since 1939. With a global presence spanning 700+ locations and a team of more than 23,000 professionals, we are dedicated to delivering scalable, innovative strategies for our customers at every step of their growth journey. Learn more at BBrown.com.
For more information:
R. Andrew Watts
Chief Financial Officer
(386) 239-5770
FAQ
How much of Brown & Brown's (BRO) buyback authorization has been used with the $250 million ASR?
Who is Brown & Brown's (BRO) counterparty for the Feb. 12, 2026 ASR and what is the amount?
When was Brown & Brown's (BRO) $1.5 billion repurchase authorization announced?
